Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of Huangshi Xiangsheng Spray (pediatric formulation) for acute pharyngitis in children
CTR20253180Phase 3Active
- Sponsor
- Wuxi Jiyu Shanhe Pharmaceutical Technology
- Start
- May 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Huangshi Xiangsheng Spray in acute pharyngitis, sponsored by Wuxi Jiyu Shanhe Pharmaceutical Technology. Started May 2026; status: active.
02
Drugs
Huangshi Xiangsheng Spray
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on CTR20253180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253180.